Company: KYIV
Filing Date: 2025-07-17
Form Type: F-4/A
Source: 0001213900-25-064873
Chunk: 43

Company: Kyivstar Group Ltd.
Filing Date: 2025-07-17
Form: F-4/A
Chunk 43
---
     |             |   4,686,515 |   |     |              |   4,686,515 |   |     |             |   4,686,515 |   |
| Investors Party to Non-Redemption Agreements                                             |     |             |     757,745 |   |     |              |     757,745 |   |     |             |     757,745 |   |
| Vesting securities – Tranches A and B                                                    |     |             |   1,323,838 |   |     |              |   1,323,838 |   |     |             |   1,323,838 |   |
| Total number of shares outstanding, as adjusted                                          |     |             |  29,768,098 |   |     |              |  18,268,098 |   |     |             |  11,819,723 |   |
| Cohen Circle’s net tangible book value per share as of March 31, 2025, as adjusted (A÷B) |     | $           |        7.38 |   |     | $            |        5.56 |   |     | $           |        3.05 |   |

The above dilution tables exclude the effects of the Business Combination itself, including the Forfeited Sponsor Shares; however, Public Shareholders who elect not to redeem their shares should anticipate further possible dilution at Closing of the Business Combination. The tables above also do not take into account: (i) the number of Kyivstar Group Ltd. Common Shares issuable upon exercise of Kyivstar Group Ltd. Warrants converted from 7,666,667 Cohen Circle Warrants that are only exercisable 30 days after the Closing Date and (ii) issuances pursuant to the long -termequity incentive plan to be implemented equal to 3.0% of the total outstanding common shares of Kyivstar Group Ltd. on a fully diluted basis. In addition, 1,323,838 Vesting Securities will not have vested as of the Closing Date are subject to forfeiture if the applicable vesting conditions are not satisfied. For a description of the vesting conditions, see the section of the proxy statement/prospectus entitled “ The Business Combination Agreement and Transaction Documents — Transaction Documents — Sponsor Agreement.” For a description of the risks regarding material potential sources of dilution to public stockholders in connection with the Business Combination